We’re excited to share a record number of research submissions this year: 📝 104 proposals received for the 19th RFP (up 55% from last year) 📚 134 abstracts submitted for the 42nd Plenary (up 23% from last year) Thank you to all who submitted their work!

[1-30 April 2025]    Humphries B, Pullenayegum E, Ohinmaa A, Jack SM, Xie F. Exploring the feasibility of using discrete choice experiment (DCE) to elicit preferences among children and adolescents: protocol for a convergent parallel mixed methods study. BMJ Open. 2025 Apr 8.   Maervoet J, Bergemann R. Potential Impact of EQ-5D-5L Mapping Function Recently Recommended…

[1-31 March 2025]  Feng J, Yin Y, Luo N, Guo J, Wang D, Mao Z, He Z, Lu C, Li S, Yu J. Performance of the EQ-5D-5L with skin irritation and self-confidence bolt-on items in patients with urticaria. Value Health. 2025 Mar 5. 2. Zhou W, Herdman M, Yang Z, Wu B, Wang P, Busschbach J,…

[1-28 February 2025]

[1-31 January 2025]

[1-31 December 2024]

REGISTRATION NOW OPEN! Following the success of the first meeting, the second meeting of EQ-5D researchers in the UK and Ireland will be held on 20 February 2025 in London. We invite researchers based in the UK and Ireland to register to participate using the following link. The meeting has been funded by the EuroQol…

[1-30 November 2024]

Over the duration of the COVID-19 pandemic emergency, the EuroQol Research Foundation offered study-specific licenses free of charge to commercial users wishing to use EQ-5D instruments in studies aimed at testing COVID-19 treatments or diagnostic tools. During this period, numerous commercial organisations undertook COVID-19 related research around the world using EQ-5D instruments – with EuroQol…

[1-31 October 2024]